切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2017, Vol. 14 ›› Issue (12) : 948 -954. doi: 10.3877/cma.j.issn.1672-6448.2017.12.014

所属专题: 文献

基础研究

超声空化促进乙醇消融兔肝脏的实验研究
益磋1, 王亚辉1, 陈重1, 高文宏1, 刘政1,()   
  1. 1. 400037 重庆,陆军军医大学第二附属医院超声科
  • 收稿日期:2017-06-20 出版日期:2017-12-01
  • 通信作者: 刘政
  • 基金资助:
    国家自然科学基金青年科学基金(81601511)

Ultrasound cavitation enhances ethanol ablation of rabbit liver

Cuo Yi1, Yahui Wang1, Zhong Chen1, Wenhong Gao1, Zheng Liu1,()   

  1. 1. Department of Ultrasound, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China
  • Received:2017-06-20 Published:2017-12-01
  • Corresponding author: Zheng Liu
  • About author:
    Corresponding author: Liu Zheng, Email:
引用本文:

益磋, 王亚辉, 陈重, 高文宏, 刘政. 超声空化促进乙醇消融兔肝脏的实验研究[J/OL]. 中华医学超声杂志(电子版), 2017, 14(12): 948-954.

Cuo Yi, Yahui Wang, Zhong Chen, Wenhong Gao, Zheng Liu. Ultrasound cavitation enhances ethanol ablation of rabbit liver[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2017, 14(12): 948-954.

目的

研究低强度超声及微泡超声空化单独或联合应用对无水乙醇消融实验兔肝脏的增强效果,并观察此方法对实验兔肝脏血流灌注、肝功能的影响。

方法

健康新西兰大白兔62只,随机分为5组:低强度超声组(LUS组,6只),无水乙醇组(EA组,14只),低强度超声联合无水乙醇组(LUS+EA组,14只),微泡超声空化联合无水乙醇组(MEUS+EA组,14只),微泡超声空化联合低强度超声增强无水乙醇组(MEUS+LUS+EA组,14只)。按分组对经腹暴露的兔肝左叶分别给予处理,LUS组、MEUS+EA组及MEUS+LUS+EA组实验兔肝脏分别于超声辐照处理后,对处理叶及对照叶即刻进行超声造影并定量分析。EA组、LUS+EA组、MEUS+EA组、MEUS+LUS+EA组各取3只实验兔于实验前、实验结束后即刻、48 h、5 d及7 d抽取动脉血检测谷丙转氨酶(ALT)、谷草转氨酶(AST)浓度。余动物于实验结束后48 h分别获取肝脏组织,排液法测量肝脏消融体积,HE染色观察肝脏处理区域组织学改变。采用配对t检验比较各组实验兔肝脏处理叶与对照叶PI、AUC差异。采用Kruskal-Walis H秩和检验比较各组实验兔肝脏消融体积,进一步组间两两比较采用Nemenyi秩和检验。采用重复测量数据的方差分析比较各组实验兔肝脏AST浓度、ALT浓度随时间变化的趋势差异。

结果

LUS组实验兔处理叶PI、AUC较对照叶稍高,但其差异均无统计学意义;MEUS+EA组、MEUS+LUS+EA组实验兔处理叶峰值强度(PI)、曲线下面积(AUC)均较对照叶降低(PI:51.65±16.90 vs 101.09±14.41,44.08±8.46 vs 113.40±9.35;AUC:2183.06±501.13 vs 4258.54±841.21,1900.39±352.59 vs 4385.55±1198.16),且差异均有统计学意义(t=9.059、16.835、9.630、7.932,P均<0.001)。LUS组实验兔未见肝脏坏死灶,肝脏消融体积为0,EA组、LUS+EA组、MEUS+EA组、MEUS+LUS+EA组实验兔肝脏消融体积分别为(0.84±0.27)、(2.42±1.11)、(3.52±1.34)、(4.01±1.45)ml,EA组实验兔肝脏消融体积均低于其余3组,且差异均有统计学意义(U=-13.800、-20.400、-23.400,P均<0.05),而其余3组间任意2组实验兔间肝脏消融体积差异均无统计学意义。LUS组实验兔肝叶超声辐照区未见明显病理改变,其余4组均出现广泛凝固性坏死。与实验前相比,实验结束后即刻各组实验兔均出现肝脏ALT及AST浓度轻微升高,实验结束后48 h达最高,随后逐渐回落,实验结束后7 d,各组实验兔肝脏ALT、AST浓度基本恢复至实验前正常水平。4组实验兔肝脏AST浓度、ALT浓度随时间变化的趋势基本一致,差异无统计学意义(F=0.256,P=0.855;F=0.517,P=0.686)。

结论

低强度超声及微泡超声空化单独或联合作用均可显著增加无水乙醇消融兔肝脏体积,且不会导致肝功能损伤加重。

Objective

To explore the effect of low intensity ultrasound (LUS) and microbubble enhanced ultrasound cavitation (MEUS), alone or in combination, on ethanol ablation (EA) of rabbit liver and observe the changes of liver perfusion and liver function.

Methods

Sixty-two healthy New Zealand rabbits were randomized to five groups: LUS group (n=6), EA group (n=14), LUS+ EA group (n=14), MEUS+ EA group (n=14), MEUS+ LUS+ EA group (n=14). For LUS, pulsed low intensity focused ultrasound emission was adopted (focal distance, 15 cm; duty cycle, 0.036%-0.22%; therapy duration, 5-6 min). According to the experiment design, surgically exposed left lobe of the liver was treated. In the LUS, MEUS+ EA, and MEUS+ LUS+ EA groups, quantitative parameters were calculated and compared between the experimental and control liver lobes after different treatments. Three rabbits in each of the EA, LUS+ EA, MEUS+ EA, and MEUS+ LUS+ EA groups were used to detect the contents of alanine aminotransferase (ALT) and aspartate transaminase (AST) in arterial blood at five different time points (before treatment, 1 h, 48 h, 5 d, and 7 d after treatment). The livers of the remaining rabbits were harvested for measurement of ethanol ablation volume by drainage method or examination of the histological changes by HE staining 48 h after treatment.

Results

In the LUS group, the peak intensity (PI) and the area under the curve (AUC) were higher in the experiment lobe than in the control lobe, but there was no significant difference. In the MEUS+ EA and MEUS+ LUS+ EA groups, the PI and AUC values were significantly lower in the experiment lobe than in the control lobe (PI: 51.65±16.90 vs 101.09±14.41, 44.08±8.46 vs 113.40±9.35; AUC: 2183.06±501.13 vs 4258.54±841.21, 1900.39±352.59 vs 4385.55±1198.16; t=9.059, 16.835, 9.630, 7.932, P<0.001 for all). In the LUS group, no necrosis was observed, and the necrosis volume was 0 ml. The necrosis volumes caused by ethanol ablation in the EA, LUS+ EA, MEUS+ EA, and MEUS+ LUS+ EA groups were (0.84±0.27) ml, (2.42±1.11) ml, (3.52±1.34) ml, and (4.01±1.45) ml. The ethanol ablation volume was significantly lower in the EA group than in the other three groups (u=-13.800, -20.400, -23.400, P<0.05 for all), although there were no significant difference between any two of the latter three groups. No pathological changes were observed in the ultrasound exposed liver of the LUS group. In contrast, a wide range of coagulation necrosis area was noted in the other four groups. Compared with pre-treatment values, ALT and AST levels in all groups showed a slight rise after treatment, peaked at 48 h, and gradually returned to the pretreatment levels after seven days. The tendency of changes in ALT and AST levels with time was similar among the four groups (F=0.256, P=0.855; F=0.517, P=0.686).

Conclusion

LUS and MEUS, alone or in combination, could significantly increase the ethanol ablated volume of rabbit liver without aggravating liver function.

图1~4 超声造影定量分析示意图。图1示低强度超声组感兴趣区勾画,白框为肝中叶感兴趣区,黄框为肝左叶感兴趣区;图2示低强度超声组超声造影时间-强度曲线,白线为对照叶,黄线为处理叶;图3为微泡超声空化联合无水乙醇组感兴趣区勾画,感兴趣区设置同前;图4为微泡超声空化联合无水乙醇组超声造影时间-强度曲线,曲线设置同前
表1 LUS组、MEUS+EA组及MEUS+LUS+EA组实验兔处理叶与对照叶CEUS定量分析结果比较(±s
图5~9 实验结束48 h后实验兔肝处理区病理表现(HE染色×100)。图5示低强度超声组未见明显病理性改变;图6示无水乙醇组可见凝固性坏死区与正常肝组织间清晰的界限(箭头所示);图7示微泡超声空化联合无水乙醇组中央动脉可见血栓形成;图8示微泡超声空化联合低强度超声增强无水乙醇组中央静脉可见大量红细胞聚集;图9示低强度超声联合无水乙醇组可见大量炎细胞浸润(箭头所示)
表2 各组实验兔不同时间点肝脏ALT浓度(×106/L,±s
表3 各组实验兔不同时间点肝脏AST浓度(×106/L,±s
1
Yu SJ, Yoon JH, Lee JM, et al. Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case-control comparative analysis [J]. Medicine (Baltimore), 2016, 95(35):e4551.
2
Facciorusso A, Serviddio G, Muscatiello N. Local ablative treatments for hepatocellular carcinoma: An updated review [J]. World J Gastrointest Pharmacol Ther, 2016, 7(4):477-489.
3
Gao W, Qiao L, Gao Y, et al. Effect of microbubble-enhanced ultrasound on percutaneous ethanol ablation of rat walker-256 tumour [J]. Eur Radiol, 2016, 26(9):3017-3025.
4
Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma [J]. Br J Surg, 2011, 98(9):1210-1224.
5
Pompili M, Saviano A, de Matthaeis N, et al. Long-term effectiveness of resection andradiofrequency ablation for single hepatocellular carcinoma≤3 cm. Results of a multicenter Italian survey [J]. J Hepatol, 2013, 59(1):89-97.
6
Liu Q, Zhao H, Wu S, et al. Impact of microbubble-enhanced ultrasound on liver ethanol ablation [J]. Ultrasound Med Biol, 2013, 39(6):1039-1046.
7
Ma S, Ding M, Li J, et al. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors [J]. J Cancer Res Clin Oncol, 2017, 143(1):131-142.
8
Cabibbo G, Antonucci M, Sacco R, et al. Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal? [J]. Expert Rev Anticancer Ther, 2015, 15(2):147-150.
9
Cha DI, Lee MW, Rhim H, et al. Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations [J]. Korean J Radiol, 2013, 14(2):240-247.
10
Zhang F, Wu G, Sun H, et al. Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: a single centre with 13 years experience [J]. Int J Hyperthermia, 2014, 30(7):471-479.
11
Kawamura R, Seki T, Umehara H, et al. Combined treatment of large hepatocellular carcinoma with transcatheter arterial chemoembolization and percutaneous ethanol injection with a multipronged needle: experimental and clinical investigation [J]. Cardiovasc Intervent Radiol, 2012, 35(2):325-333.
12
Li D, Kang J, Madoff D C. Locally ablative therapies for primary and metastatic liver cancer [J]. Expert Rev Anticancer Ther, 2014, 14(8):931-945.
13
Fu Y, Zhao X, Yun Q, et al. Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials [J]. Int J Clin Exp Med, 2015, 8(7):10388-10400.
14
Xu C, Lv PH, Huang XE, et al. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma [J]. Asian Pac J Cancer Prev, 2016, 17(9):4349-4352.
15
张金龙,赵晓晨,薛雯, 等. 超声引导下局部注射凝血酶联合无水乙醇消融兔正常肝脏组织 [J]. 中国医学影像技术, 2013, 29(4):503-506.
16
高顺记,李佩倞,赵洋, 等. 微泡增强的超声空化阻断肿瘤微循环的初步研究 [J]. 中国超声医学杂志, 2010, 26(2):110-112.
17
钟渝,陈重,陈礼波, 等. 诊断超声联合微泡对肿瘤微循环的作用 [J]. 中国医学影像技术, 2013, 29(5):688-692.
18
刘青,吴盛正,皋月娟, 等. 超声空化阻断对兔肝血流灌注的影响 [J]. 中国医学影像技术, 2012, 28(8):1440-1444.
[1] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[2] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[3] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[4] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[8] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[9] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[10] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[11] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
[12] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[13] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
[14] 韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
[15] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?